Emodin Ameliorates LPS-Induced Acute Lung Injury, Involving the Inactivation of NF-κB in Mice

Chronic Inflammatory Diseases and the Acute Respiratory Distress Syndrome (ARDS)

(2014) Ana Fernandez-Bustamante et al.   CURRENT PHARMACEUTICAL DESIGN

Emodin inhibits LPS-induced inflammatory response by activating PPAR-γ in mouse mammary epithelial cells

(2014) Zhengtao Yang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Deregulation of inflammatory response in the diabetic condition is associated with increased ischemic brain injury

(2014) Eunhee Kim et al.   Journal of Neuroinflammation

Anti-inflammatory effects of triptolide by inhibiting the NF-κB signalling pathway in LPS-induced acute lung injury in a murine model

(2014) XIAN WANG et al.   Molecular Medicine Reports

Effect of siRNA against NF-κB on sepsis-induced acute lung injury in a mouse model

(2014) LI-YAN JIN et al.   Molecular Medicine Reports

Emodin up-regulates glucose metabolism, decreases lipolysis, and attenuates inflammation in vitro大黄素在体内上调糖代谢、减少脂解和抑制炎症反应

(2014) Xiaoyan Zhang et al.   Journal of Diabetes

The Berlin Definition of ARDS versus Pathological Evidence of Diffuse Alveolar Damage

(2013) B. Taylor Thompson et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pharmacological treatments in ARDS; a state-of-the-art update

(2013) Andrew James Boyle et al.   BMC Medicine

ARDS: progress unlikely with non-biological definition

(2013) S. Fröhlich et al.   BRITISH JOURNAL OF ANAESTHESIA

Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activityin vitroandin vivo

(2013) N Fakhrudin et al.   BRITISH JOURNAL OF PHARMACOLOGY

NF-κβ signaling and chronic inflammatory diseases: exploring the potential of natural products to drive new therapeutic opportunities

(2013) Matthew J. Killeen et al.   DRUG DISCOVERY TODAY

Emodin ameliorates lipopolysaccharide-induced mastitis in mice by inhibiting activation of NF-κB and MAPKs signal pathways

(2013) Depeng Li et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury

(2013) Wanzhi Lv et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Emodin attenuates high glucose-induced TGF-β1 and fibronectin expression in mesangial cells through inhibition of NF-κB pathway

(2013) Jie Yang et al.   EXPERIMENTAL CELL RESEARCH

Effect of Emodin on Endoplasmic Reticulum Stress in Rats with Severe Acute Pancreatitis

(2013) Li Wu et al.   INFLAMMATION

Protective Role of Andrographolide in Bleomycin-Induced Pulmonary Fibrosis in Mice

(2013) Tao Zhu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Andrographolide Protects against LPS-Induced Acute Lung Injury by Inactivation of NF-κB

(2013) Tao Zhu et al.   PLoS One

Biomarkers of ALI/ARDS: Pathogenesis, Discovery, and Relevance to Clinical Trials

(2013) Lorraine Ware et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Autopsy in ARDS: insights into natural history

(2013) Lorraine B Ware   Lancet Respiratory Medicine

Treating ARDS: new hope for a tough problem

(2013) Jeffrey E Gotts et al.   Lancet Respiratory Medicine

Pharmacological Therapies for Pediatric and Neonatal ALI/ARDS: An Evidence-Based Review

(2012) Daniele De Luca et al.   CURRENT DRUG TARGETS

Pattern recognition receptors acting in innate immune system of shrimp against pathogen infections

(2012) Xian-Wei Wang et al.   FISH & SHELLFISH IMMUNOLOGY

Insulin up-regulates epithelial sodium channel in LPS-induced acute lung injury model in rats by SGK1 activation

(2012) Tao Zhu et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

Year in review in Intensive Care Medicine 2011: III. ARDS and ECMO, weaning, mechanical ventilation, noninvasive ventilation, pediatrics and miscellanea

(2012) Massimo Antonelli et al.   INTENSIVE CARE MEDICINE

The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material

(2012) Niall D. Ferguson et al.   INTENSIVE CARE MEDICINE

Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway

(2012) Zenglin Liao et al.   RESPIRATORY RESEARCH

Definition of ALI/ARDS

(2011) Krishnan Raghavendran et al.   CRITICAL CARE CLINICS

Gene Therapy for ALI/ARDS

(2011) Xin Lin et al.   CRITICAL CARE CLINICS

Novel Interventional Approaches for ALI/ARDS: Cell-Based Gene Therapy

(2011) Ying-Gang Zhu et al.   MEDIATORS OF INFLAMMATION

ZLJ-6, a novel COX/5-LOX inhibitor, attenuates TNF-α-induced endothelial E-selectin, ICAM-1 and VCAM-1 expression and monocyte–endothelial interactions via a COX/5-LOX-independent mechanism

(2011) Li Chen et al.   VASCULAR PHARMACOLOGY

Innate immunity in the human lung: pathogen recognition and lung disease

(2010) Kristina Rohmann et al.   CELL AND TISSUE RESEARCH

ARDS outcomes: a marker of critical care quality in the UK?

(2010) M. P. Wise et al.   THORAX

The carbon monoxide releasing molecule (CORM-3) inhibits expression of vascular cell adhesion molecule-1 and E-selectin independently of haem oxygenase-1 expression

(2009) H Song et al.   BRITISH JOURNAL OF PHARMACOLOGY

INHIBITORY EFFECT OF EMODIN ON BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN MICE

(2008) Xiao-Hong Chen et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY